Literature DB >> 24684961

Observation of ovarian cancer stem cell behavior and investigation of potential mechanisms of drug resistance in three-dimensional cell culture.

Junsong Chen1, Jing Wang2, Yunxia Zhang3, Dengyu Chen1, Cuiping Yang1, Cai Kai1, Xiaoying Wang1, Fangfang Shi4, Jun Dou5.   

Abstract

Cancer cells behave differently in a three-dimensional (3D) cell culture compared with in the conventional two-dimensional (2D) one. Accumulated evidences indicate that the characteristics of cancer stem cells (CSCs) are different from common cancer cells due to their ability to produce tumors and resist chemoradiation. The objective of this work was to observe CSC behavior and investigate the potential mechanisms of CSC drug resistance in 3D versus 2D in vitro environment. We first demonstrated that the CD44(+)CD117(+)cells isolated from the human epithelial ovarian cancer HO8910 cell line have the properties of CSCs that revealed faster growth, larger tumorsphere and stronger survival potential in the hypoxic environment in 3D cell culture as well as more powerful tumorigenicity in a xenograft mice than the HO8910 cells. The CD44(+)CD117(+)CSCs also exhibited high chemoresistance to anticancer drugs when the cells were incubated with 5-fluorouracil, cisplatin and carboplatin, respectively in 3D versus 2D environment. This might be associated with the high expression of ABCG2, ABCB1 and the high expression of MMP-2 and MMP-9 in CD44(+)CD117(+)CSCs. Overall, these results suggest the advantages of using 3D culture model to accurately display CSC behavior in vitro. 3D model may improve the efficacy of screening anticancer drugs for treatment of ovarian CSCs.
Copyright © 2014 The Society for Biotechnology, Japan. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Chemoresistance; Epithelial ovarian cancer; Three-dimensional culture; Two-dimensional culture

Mesh:

Substances:

Year:  2014        PMID: 24684961     DOI: 10.1016/j.jbiosc.2014.01.008

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  24 in total

1.  MCT1 promotes the cisplatin-resistance by antagonizing Fas in epithelial ovarian cancer.

Authors:  Chunxiao Yan; Fan Yang; Chunxia Zhou; Xuejun Chen; Xuechuan Han; Xueqin Liu; Hongyun Ma; Wei Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

Authors:  Courtney A Penn; Kun Yang; Hong Zong; Jae-Young Lim; Alex Cole; Dongli Yang; James Baker; Sascha N Goonewardena; Ronald J Buckanovich
Journal:  Mol Cancer Ther       Date:  2017-11-13       Impact factor: 6.261

3.  Three-dimensional cell culture: A powerful tool in tumor research and drug discovery.

Authors:  Donglai Lv; Zongtao Hu; Lin Lu; Husheng Lu; Xiuli Xu
Journal:  Oncol Lett       Date:  2017-10-03       Impact factor: 2.967

4.  MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.

Authors:  Jing Han; Qianxue Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population.

Authors:  Rachel Eyre; Ian Harvey; Katherine Stemke-Hale; Thomas W J Lennard; Alison Tyson-Capper; Annette P Meeson
Journal:  Tumour Biol       Date:  2014-07-04

6.  Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer.

Authors:  Neha Aggarwal; Ann Marie Santiago; David Kessel; Bonnie F Sloane
Journal:  Breast Cancer Res Treat       Date:  2015-10-26       Impact factor: 4.872

7.  Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer.

Authors:  Muhammad Ary Zucha; Alexander T H Wu; Wei-Hwa Lee; Liang-Shun Wang; Wan-Wan Lin; Chiou-Chung Yuan; Chi-Tai Yeh
Journal:  Oncotarget       Date:  2015-05-30

Review 8.  Expression and Function of CD44 in Epithelial Ovarian Carcinoma.

Authors:  Joelle D Sacks; Maria V Barbolina
Journal:  Biomolecules       Date:  2015-11-11

9.  Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.

Authors:  Di Wu; Jing Wang; Yunlang Cai; Mulan Ren; Yuxia Zhang; Fangfang Shi; Fengshu Zhao; Xiangfeng He; Meng Pan; Chunguang Yan; Jun Dou
Journal:  J Ovarian Res       Date:  2015-10-24       Impact factor: 4.234

10.  Isolation and characterization of side population cells from the human ovarian cancer cell line SK-OV-3.

Authors:  Zhengyi Ruan; Jianhua Liu; Yanping Kuang
Journal:  Exp Ther Med       Date:  2015-10-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.